International Society for the Study of Women's Sexual Health

ISSWSH ISSUES IMPORTANT UPDATES FOR HSDD THERAPIES

ISSWSH is pleased to provide the following updates related to therapies for Hypoactive Sexual Desire Disorder or HSDD. The FDA has updated prescribing information for flibanserin, removed the REMS certification requirement for prescribers and pharmacists, and updated safety information related to the alcohol contraindication. In addition, bremelanotide has now been approved for treatment of HSDD. Please see the attached news release related to these two therapies for more specific information and references.

News Release

Save the Date

ISSWSH Annual Meeting 2020
March 5-8, 2020   37 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

ISSWSH Sexual Pain Course 2020
April 17-18, 2020 80 days left
Georgetown University Medical Center, Medical and Dental Building, Washington, DC, USA
Read more...

ISSWSH Fall Course 2020
November 19-21, 2020   296 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2021
March 4-7, 2021   401 days left
Renaissance Dallas Hotel, Dallas, TX, USA

Latest Tweets

Need help with a patient? Or want to share your experiences with others? Check out the Community Forum! https://t.co/Kfz1JkjOh6 ISSWSH
ISSWSH is having it's annual meeting in #2020 in Orland, FL. March 5-8th! Don't forget to mark it in your calendar… https://t.co/GXoEECAbQQ ISSWSH
Registration for the ISSWSH Sexual Pain Course is still open, but hurry, space is limited! https://t.co/4XTF1jxt9T ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!